Ahmar U. Zaidi, MD: As far as preventive therapies go, hydroxyurea is the mainstay of therapy in sickle cell disease. And hydroxyurea is quite an interesting drug that has been studied very ...

Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...

SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...

Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...

Please provide your email address to receive an email when new articles are posted on . Despite it being the standard of care for treating vasocclusive disease associated with sickle cell disease, ...

Children with sickle cell disease had improved lung function after treatment with hydroxyurea, according to a study presented at the American Thoracic Society (ATS) 2016 International Conference.

Clinical research led by Indiana University School of Medicine investigators and their collaborators in Uganda has revealed that hydroxyurea significantly reduces infections in children with sickle ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

Hydroxyurea may falsely elevate sensor glucose results from certain CGM systems. The prescribing information for hydroxyurea has been updated to include information regarding patients who use ...

A 73-year-old man with a history of chronic myelogenous leukemia presented with multiple ulcers on both legs (Figure 1). The ulcers were extremely painful. The patient had no history of diabetes or ...

Please provide your email address to receive an email when new articles are posted on . Toxicity on spermatogenesis may not be a major concern for boys with severe sickle cell disease who require ...